| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.29 | 0.07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |